DPYSL5 and paraneoplastic neurologic syndrome: Another patient with ADEM-ON tested positive for CRMP5-IgG at a low titer (1:10) and had no evidence of malignancy; follow-up is ongoing to evaluate the possibility of paraneoplastic neurological syndrome [29].